GET THE APP

Markers found in macrophages using proteomics can function as tar | 29192
Journal of Proteomics & Bioinformatics

Journal of Proteomics & Bioinformatics
Open Access

ISSN: 0974-276X

+44 1223 790975

Markers found in macrophages using proteomics can function as targets for chemotherapeutic intervention of Leishmania infection


5th International Conference on Proteomics & Bioinformatics

September 01-03, 2015 Valencia, Spain

Patr�?­cia Sampaio Tavares Veras1, Petersen A L OA1,2, Cull B2, Guedes C E S1,3, Fullam J P B M1 and Mottram J C2

1Gon�?§alo Moniz Research Center- FIOCRUZ, Brazil 2University of Glasgow, UK 3Universidade Federal da Bahia, Brazil

Scientific Tracks Abstracts: J Proteomics Bioinform

Abstract :

Leishmaniasis has been treated by antimonial pentavalents for the last 70 years. However, the efficacy of leishmaniasis treatment is under scrutiny due to the rise of drug-resistant cases. To find in macrophages potential targets for alternative chemotherapeutic intervention against Leishmania infection, we employed a proteomic approach that allowed the identification of proteins whose expression changes in Leishmania-infected macrophages that might function as novel targets for leishmaniasis treatment. Using this proteomic approach, we found a total of 162 proteins modulated in macrophages upon Leishmania infection. Among them, a total of 15 proteins showed greater differences in expression in infected macrophages, and at least one of them, HIF-1�?± has the potentiality to be modulated by specific drugs. HIF-1�?± is one of the client proteins of the heat-shock protein (HSP)-90, a molecular chaperone that is highly abundant in mammalian cells and known to be induced during stress responses. This ATP-dependent chaperone is known to be involved in the stabilization, correct folding, and assembly of several client proteins including HIF-1�?±. Protozoan parasites also express HSP90, which is known to play a crucial role in the stabilization of heat-labile proteins within these cells. Herein we describe the modulation of Leishmania infection using in infected macrophages of 17-AAG, a benzoquinone ansamycin antibiotic that is a specific inhibitor of HSP90, treatment of infected macrophages with 17-AAG significantly reduced both the percentage of infected cells and parasite load in a dose- and time-dependent manner. Intracellular parasite death occurred independent of nitric oxide and superoxide production. Electron microscopy revealed morphological alterations suggestive of 17-AAG-induced parasite death results from an autophagic process. Further investigation using parasite mutants of the components of the autophagic pathway, such as GFPATG8 and ATG5-KO reinforces the notion that 17-AAG induced the formation of autophagic vacuoles in parasites. In addition, the 17-AAG induced autophagosomes showing reduced fusion between autophagosomes and lysosome/glycosome. These suggest that 17-AAG induced autophagic vacuoles that do not mature to autolysosomes that could be responsible for parasite death.

Biography :

Patrícia Sampaio Tavares Veras graduated from the School of Medicine of the Federal University of Bahia and completed her PhD in the Department of Immuneparasitology of the Pasteur Institute in Paris. She currently works as a Researcher at the Gonçalo Moniz Research Center, a division of the Oswaldo Cruz Foundation (CPqGM/ FIOCRUZ). She has experience in the fields of cellular and molecular biology, specifically in the area of cellular biology of host-pathogen interactions. She focused her research efforts on interactions between murine macrophages and Leishmania spp. Her group has developed studies concerning murine macrophages using large-scale approaches, aiming to identify molecules within macrophages that play crucial role on the course of Leishmania infection. Her group found promising molecules that proved to be useful as chemotherapeutic targets in therapeutic applications to fight against leishmaniasis.

Email: pstveras@gmail.com

Top